News and Insights

Appearing on the Health Care Rounds podcast, Evolent Senior Director for Value Transformation Kamal Golla explains why value-based specialty care is primed for growth.

Writing in Evidence-Based Oncology, Evolent’s vice president of pharmacy highlights the challenges around ensuring that “fast-track” cancer therapies deliver on their initial promise.

Could generative AI replace expert consensus for devising clinical guidelines? Our chief medical officer takes a look.

To reduce the fragmentation of care for complex conditions, we need to take on the fee-for-service models that contribute to it, says Evolent’s Dr. Vishnukamal Golla.

A stronger, unified voice in our scientific community will impact the accessibility of genetic testing so that it becomes standard preventive care for everyone who qualifies — and who wants it.

Cancer treatment and the time spent traveling for care are often very time-consuming. By recognizing and working to decrease time toxicity for patients with cancer, we can lessen their burden.

Barriers related to implantable devices often keep orthopedic procedures from being peformed outside the hospital.

Joint offering will seek to to enable more coordinated, connected and empowered journeys for people living with cancer in the U.S.